Company
Deep Track Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Superluminal Medicines | Series B | 2026-09-03 | |
| Triveni Bio | Series C | 2026-06-17 | |
| Ambrosia Biosciences | Series B | 2026-03-31 | Lead |
| Diagonal Therapeutics | Series B | 2026-01-09 | |
| Avenzo Therapeutics | Series B | 2025-09-22 | |
| Attovia Therapeutics | Series C | 2025-04-16 | Lead |
| Imbria Pharmaceuticals | Series B | 2025-04-11 | Lead |
| Latigo Biotherapeutics | Series B | 2025-03-17 | |
| Maze Therapeutics | Series D | 2024-12-03 | Lead |
| Triveni Bio | Series B Funding | 2024-10-02 | |
| Halda Therapeutics | Series B | 2024-08-12 | |
| TORL BioTherapeutics | Series B-2 Funding | 2024-04-10 | Lead |
| Avenzo Therapeutics | Series A1- Financing | 2024-03-27 | Lead |
| Mariana Oncology | Series B Funding | 2023-09-07 | Lead |
| Zura Bio | Financing | 2023-06-06 | Lead |
| Carmot Therapeutics | Series E Equity Financing | 2023-05-31 | Lead |
| TORL BioTherapeutics | Series B Financing | 2023-04-13 | |
| Apogee Therapeutics | Series B | 2022-12-12 | Lead |
| Lusaris Therapeutics | Series A | 2022-11-07 |